State-owned NHPC on Saturday said it will extend a financial assistance of Rs 4.5 crore to fight the spread of coronavirus. The decision was taken by NHPC CMD A K Singh during a meeting with senior company officials through video conferencing, the company said.
"In view of the coronavirus (COVID-19) crisis that has hit the entire world and the nation, NHPC Ltd has earmarked Rs 4.5 crore to fight the COVID-19 pandemic in the country," it said.
Out of Rs 4.5 crore, Rs 1.3 crore has been contributed by its employees, it said, adding the fund will be used to fight the pandemic.
As part of the relief work, NHPC has developed a 40 bed quarantine centre which is being managed with the help of government authorities.
Besides, NHPC hospitals and dispensaries have been instructed to provide 24 x7 OPD services.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.